RingMD Founder Justin Fulcher on Selling a Company the Right Way
OnWhen Justin Fulcher sold RingMD in 2018, he was careful about how he framed it. He did not describe the transaction as an exit..
Read MoreDr. Andrew Jacono on How Video Calls Changed Facelift Demand
OnRemote work did something unexpected to the facial plastic surgery market. It put faces on screens for hours at a time, under high-definition cameras,.
Read MoreEurope’s Deadly Summer Exposes Urban Heat Vulnerability
OnLast summer, southern Europe experienced 23 tropical nights—when temperatures never drop below 20°C—nearly triple the historical average. The consequences were devastating: 24,400 people died.
Read MoreHeather Dixon Appointed CFO at Acadia Healthcare as Company Eyes Major Expansion
OnIn a significant development for Acadia Healthcare Company, Heather Dixon has been appointed as the new Chief Financial Officer (CFO), a move effective from July 10,.
Read MoreBlarcamesine Shows Promising Results in Alzheimer’s Phase 2b/3 Trial
OnAnavex Life Sciences has announced groundbreaking results from its recent Phase 2b/3 clinical trial involving the investigational drug blarcamesine. This trial assessed the drug’s.
Read MoreBlarcamesine Shows Promise in Reducing Alzheimer’s Biomarkers in Phase 2b/3 Trial
OnA recent study by Anavex Life Sciences has unveiled promising results for their investigational Alzheimer’s agent, blarcamesine. The phase 2b/3 trial, conducted across multiple.
Read MoreAnavex Life Sciences Continues to Make Strides in Neurological Research
OnAnavex Life Sciences, a leading pharmaceutical company, continues to make significant advancements in the realm of neurological research. Through their unwavering commitment to innovate,.
Read More